Comorbidity between hepatitis C and depression: Epidemiological and etiopathogenic aspects;Comorbilidade entre hepatite C e depressão: Aspectos epidemiológicos e etiopatogénicos

Acta Medica Portuguesa

Volumn 19, Issue 1, 2006, Pages 21-28

  Neves, António Cruz ^a   Dickens, Christopher ^a   Xavier, Miguel ^a  

^a NONE

Author keywords

Epidemiological and etiopathogenic aspects; Hepatitis C; depression

Indexed keywords

CYTOKINE;

CENTRAL NERVOUS SYSTEM; COMORBIDITY; DISABILITY; FATIGUE; FUNCTIONAL DISEASE; HEPATITIS C; HUMAN; MAJOR DEPRESSION; MENTAL DISEASE; PERCEPTION; PREVALENCE; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; REVIEW;

COMORBIDITY; DEPRESSION; HEPATITIS C, CHRONIC; HUMANS;

EID: 33646784743     PISSN: None     EISSN: 16460758     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. World Health Organization:: Global surveillance and control of hepatitis C. J Viral Hepatitis 1999; 6:35-47
2. ALTER M, KRUSZON-MORAN D, NAINAN O et al: The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341:556-62
3. THOMAS DL: Hepatitis C epidemiology. In: Compans RW, Cooper M, Hogle JM, et al, eds. Current Topics in Microbiology and Immunology. Vol 237. Berlin, Germany, Springer-Verlag GmbH & Co. 1999; 25-41
4. NIH Consensus Program: National Institutes of Health consensus development conference panel statement: management of hepatitis C. Hepatology. 1997; 26:2S-10S
5. LAUER GM, WALKER BD: Hepatitis C virus infection. N Engl J Med. 2001; 345:41-52
6. DIEPERINK E, WILLENBRING M, HO S: Neuropsychiatric symptoms associated with hepatitis C and interferon alpha: A review. Am J Psychiatry 2000; 157(6):867-876
7. JOHNSON ME, FISHER DG, FENAUGHTY A, THENO SA: Hepatitis C virus and depression in drug users. Am J Gastroenterol 1998; 93(5):785-789
8. NGUYEN H, MILLER B, DIEPERINK E et al: Spectrum of disease in US veteran patients with hepatitis C. Am J Gastroenterol 2002; 97:1813-20
9. DIEPERINK E, HO SB, THURAS P, WILLENBRING ML: A prospective study of neuropsychiatric symptoms associated with interferon-±-2b and Ribavirin Therapy for patients with Chronic Hepatitis C. Psychosomatics 2003; 44(2):104-112
10. th ed. APA, Washington, DC, 1994
11. COUGHLAN B, SHEEHAN J, HICKEY A, CROWE J: Psychological well-being and quality of life in women with an iatrogenic hepatitis C virus infection. Brit J Health Psychol 2002; (7):105-116
12. GOULDING C, O'CONNELL P, MURRAY FE: Prevalence of fibromyalgia, anxiety and depression in chronic hepatitis C virus infection: relationship to RT-PCR status and mode of acquisition. Eur J Gastroenterol and Hepatol 2001;13(5):507-511
13. KRAUS MR, SCHAFER A, CSEF H, SCHEURLEN M, FALLER H: Emotional state, coping styles, and somatic variables in patients with chronic hepatitis C. Psychosomatics 2000; 41 (5):377-384
14. GALLEGOS-OROZCO J, FUENTES AP, ARGUETA JG et al: Health-Related Quality of Life with Chronic Hepatitis C. Archives of Medical Research 2003; 34:124-129
15. MCDONALD J, JAYASRIYA R, BINDLEY P, GONSALVEZ C, GLUSESKA S: Fatigue and psychological disorders in chronic hepatitis C. J Gastroenterol and Hepatol 2002; 17:171-176
16. LEHMAN CL, CHEUNG C: Depression, anxiety, post-traumatic stress, and alcohol-related problems among veterans with chronic hepatitis C. Am J Gastroenterol 2002; 97(10):2640-2646
17. DWIGHT MM, KOWDLEY K, RUSSO KV, CIECHANOWSKI PS, LARSON AM, KATON WJ: Depression, fatigue, and functional disability in patients with chronic hepatitis C. J Psychosomatic Research 2000; 49:311-317
18. YOVTCHEVA SP, RIFAL MA, MOLES JK, VAN DER LINDEN BJ: Psychiatric comorbidity among hepatitis C-positive patients. Psychosomatics 2001; 42 (5):411-415
19. EL-SERAG H, KUNIK M, RICHARDSON P et al: Psychiatric disorders among veterans with hepatitis C infection. Gastroenterol 2002; 123:476-82
20. WESSELY S, PARIANTE C: Fatigue, depression and chronic hepatitis C infection. Psychological Medicine 2002; 32:1-10
21. RADKOWSKI M, WILKINSON J, NOWICKI M et al: Search for hepatitis C virus negative-strand RNA sequences and analysis of viral sequences in the central nervous system: Evidence of replication. J Virol 2002; 76:600-608
22. KRAMER L, BAUER E, HOFER H et al: Cognitive brain function in subclinically impaired in patients with chronic hepatitis C: Does hepatitis C affect the brain? Gastroenterol 2000; 118:A251 (abst).
23. KRAMER L, BAUER E, FUNK G et al: Sub clinical impairment of brain function in chronic hepatitis C infection. J Hepatology 2002; 37:349-54
24. FORTON DM, THOMAS HC, MURPHY CA et al: Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatol 2002; 35:433-9
25. FORTON DM, ALLSOP JM, MAIN J et al.: Evidence for a cerebral effect of the hepatitis C virus. Lancet 2001; 358:38-39
26. LASKUS T, RADKOWSKI M, WANG LF et al: Search for hepatitis C virus extrahepatic replication sites in patients with acquired immunodeficiency syndrome: Specific detection of negative-strand viral RNA in various tissues. Hepatol 1998; 28:1398-1401
27. LASKUS T, RADKOWSKI M, PIASEK A et al: Hepatitis C virus in lymphoid cells of patients coinfected with human immunodeficiency virus type 1: Evidence of active replication in monocytes/macrophages and lymphocytes. J Infect Dis 2000; 181:442-448
28. LASKUS T, RADKOWSKI M, BEDNARSKA A et al: Detection and analysis of hepatitis C virus sequences in cerebrospinal fluid. J Virol 2002; 76:10064-8
29. MORSICA G, BERNARDI MT, NOVATI R et al: Detection of hepatitis C virus genomic sequences in the cerebrospinal fluid of HIV infected patients. J Med Virol 1997;53:252-254
30. BOLAY H, SOYLEMEZOGLU F, NURLU G et al: PCR detected hepatitis C virus genome in the brain of a case with progressive encephalomyelitis with rigidity. Clin Neurol Neurosurg 1996; 98:305-308
31. MAGGI F, GIORGI M, FORNAI C et al: Detection and quasispecies analysis of hepatitis C virus in cerebrospinal fluid of infected patients. J Neurovirol 1999; 5:319-323
32. TILG H, WILMER A, VOGEL W et al: Serum levels of cytokines in chronic liver diseases. Gastroenterol 1992; 103:274-284
33. GONZALES-AMARO R, GARCIA-BUEY L, MORENO-OTERO R et al: Induction of tumor necrosis factor alpha production by human hepatocytes in chronic viral hepatitis. J Exp Med 1994;179:841-848
34. FUKUDA R, SATOH S, NGUYEN X et al: Expression rate of cytokine mRNA in the liver of chronic hepatitis C: comparison with chronic hepatitis B. J Gastroenterol 1995;30:41-47
35. SHINDO M, BRAUN-ELWERT L, BERGASA N, JONES E, JAMES S: Cytokine mRNA expression in the liver of patients with primary biliary cirrhosis (PBC) and chronic hepatitis B (CHB). Clni Exp Immunol 1996; 105:254-259
36. HUANG Y, HWANG S, CHAN C et al: Serum levels of cytokines in hepatitis C-related liver disease: a longitudinal study. Chung Hua I Hseuh Tsa Chih (Taipei) 1999; 62:327-333
37. KENT S, BLUTHE R, KELLEY K, DANTZER R: Sickness behavior as a new target for drug development. Trends in Pharmacological Sciences 1992; 13:24-28
38. MAES M, SCHARPE S, MELTZER H et al: Relationship between interleukin-6 activity, acute phase proteins, and the function of the hypothalamic-pituitary- adrenal axis in severe depression. Psychiatry Research 1993; 49:11-27